ALT
Altimmune·NASDAQ
--
--(--)
--
--(--)
7.69 / 10
Outperform
Two analysts issue Strong‑Buy ratings despite a 16.6% price drop. Fund‑flow scores 7.64/10 with modest inflow ratios (~0.47) across all investor sizes, though trends are negative. Sentiment remains positive, supporting a cautiously optimistic outlook.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-16
InstitutionHC Wainwright & Co.
Times predicted3
Historical Win Rate66.7%
What is the analyst consensus for ALT?
- ALT holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.69/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
